Publikationen

Nachfolgend finden Sie eine Auflistung der in medline gelisteten Publikationen mit dem Thema klinische oder experimentelle Transplantation aus dem Transplantationzentrum der Uniklinik Köln. Weitere wissenschaftliche Arbeiten der einzelnen Mitarbeiterinnen und Mitarbeiter können Sie auf den Teamseiten oder durch eine Suchanfrage bei PubMed finden.


2015

Wahba R, Franke M, Hellmich M, Kleinert R, Cingöz T, Schmidt MC, Stippel DL, Bangard C.: Computed Tomography Volumetry in Preoperative Living Kidney Donor Assessment for Prediction of Split Renal Function. Transplantation. 2015 Sep 9. [Epub ahead of print]

Dieplinger G, Everly MJ, Briley KP, Haisch CE, Bolin P, Maldonado AQ, Kendrick WT, Kendrick SA, Morgan C, Terasaki PI, Rebellato LM.: Onset and progression of de novo donor-specific anti-human leukocyte antigen antibodies after BK polyomavirus and preemptive immunosuppression reduction. Transpl Infect Dis. 2015 Oct 7. doi: 10.1111/tid.12467 [Epub ahead of print] (Dr. Dieplinger hat 2013 und 2014 an der Terasaki Foundation gearbeitet.)

Houben P, Manzini G, Kremer M, Arend J, Berlakovich GA, Klar E, Klempnauer J, Lerut J, Otto G, Pirenne J, Rogiers X, Seehofer D, Stippel DL, Schemmer P: Graft rinse prior to reperfusion in liver transplantation: literature review and online survey within the Eurotransplant community. Transpl Int. 2015 Nov;28(11):1291-8.

 


2014

Dirk L. Stippel, D.L., Cingöz, T., Wahba, R., Müller, R.-U., Bauerfeind, U., Dieplinger, G.: 25 Years of Kidney Transplantation - A Period of Change. Clinical Transplants 2014

Dieplinger, G., Ditt, V., Arns, W., Huppertz, A., Kisner, T., Hellmich, M.,
Bauerfeind, U., Stippel, D.L.: Impact of de novo donor-specific HLA antibodies detected by Luminex solid phase assay after transplantation in a group of 88 consecutive living donor renal transplantations. Transplant Int 2014 27:60-8

 


2013

Kleinert R, Wahba R, Heiermann N, Kisner T, Hos N, Stippel DL: Prognosis after "high urgent" kidney transplantation might be determined by control of preexisting septic condition. Transplant Proc. 2013 Jan;45(1):95-8

Manzini, G., Kremer, M., Houben, P., Gondan, M., Bechstein, W., Becker, T., Berlakovich, G., Friess, H., Guba, M., Hohenberger, W., IJzermans, J., Jonas, S., Kalff, J., Klar, E., Klempnauer, J., Lerut, J., Lippert, H., Lorf, T., Nadalin, S., Nashan, B., Otto, G., Paul, A., Pirenne, J., Pratschke, J., Ringers, J., Rogiers, X., Schilling, M., Senninger, N., Seehofer, D., Settmacher, U., Stippel, D., Tscheliessnigg, K., Ysebaert, D., Binder, H., Schemmer, P.: Reperfusion of liver graft during transplantation: techniques used in transplant centres within Eurotransplant and metaanalysis of the literature. Transplant Int 2013 26:508-16

Shimabukuro-Vornhagen A, Schlösser H, Kisner T, Stippel DL, von Bergwelt-Baildon M: The Use of Statins in Hematopoietic Stem Cell Transplantation and Solid Organ Transplantation. Curr Stem Cell Res Ther. 2013 Jan (epub)

 


2012

Langenbach, M., Stippel, A., Stippel, D.: Living Kidney Donation—Subjective Experiences of Donors before and Two Years after Donation. OJOTS 2012;2(4) (DOI: 10.4236/ojots.2012.24006)

Teschner S, Stippel D, Grunenberg R, Beck B, Wahba R, Gathof B, Benzing T, Burst V:
ABO-incompatible kidney transplantation using regenerative selective immunoglobulin adsorption. J Clin Apheresis 2012;27(2):51-60

Beck BB, Habbig S, Dittrich K, Stippel D, Kaul I, Koerber F, Goebel H, Salido EC, Kemper M, Meyburg J, Hoppe B: Liver cell transplantation in severe infantile oxalosis--a potential bridging procedure to orthotopic liver transplantation? Nephrol Dial Transplant. 2012;27(7): 2984-9

Knudsen L, Boxler L, Muhlfeld C, Schaefer IM, Becker L, Bussinger C, von Stietencron I, Madershahian N, Richter J, Wahlers T, Wittwer T, Ochs M: Lung preservation in experimental ischemia/reperfusion injury and lung transplantation: a comparison of natural and synthetic surfactants. J Heart Lung Transplant. 2012;31(1):85-93


2011
Wippermann J, Hoppe UC, Sreeram N, Wahlers T. Failed closure of a ventricular septal defect with an Amplatzer occluder. Interact Cardiovasc Thorac Surg 2011;10(2):320-1.

Hoppe B, Dittlich K, Fehrenbach H, Plum G, Beck BB: Reduction of plasma oxalate levels by oral application of Oxalobacter formigenes in 2 patients with infantile oxalosis. Am J Kidney Dis 2011;58(3): 453-455

Wahba R, Teschner S, Stippel DL. Results of kidney transplantation after rescue allocation. Transpl Int 2011;24(6):e46-7.

Knudsen L, Waizy H, Fehrenbach H, Richter J, Wahlers T, Wittwer T, Ochs M: Ultrastructural changes of the intracellular surfactant pool in a rat model of lung transplantation-related events. Respir Res. 2011;14(12):79

Burst VR, Gillis M, Putsch F, Herzog R, Fischer JH, Heid P, et al. Poor cell survival limits the beneficial impact of mesenchymal stem cell transplantation on acute kidney injury. Nephron Exp Nephrol 2011;114(3):e107-16.

Burst V, Benzing T. Dyslipidemia treatment and cardiovascular disease in the renal patient. Curr Pharm Des 2011;17(9):894-907.

Bergstralh EJ, Monico CG, Lieske JC, Herges RM, Langman CB, Hoppe B, et al. Transplantation outcomes in primary hyperoxaluria. Am J Transplant 2011;10(11):2493-501.


2010
Teschner S, Burst V. Leflunomide: a drug with a potential beyond rheumatology. Immunotherapy 2010;2(5):637-50.

Spasovski G, Beck BB, Blau N, Hoppe B, Tasic V. Late diagnosis of primary hyperoxaluria after failed kidney transplantation. Int Urol Nephrol 2010;42(3):825-9.

Fangmann J, Arns W, Marti HP, Hauss J, Ketteler M, Beckurts T, et al. Impact of daclizumab, low-dose cyclosporine, mycophenolate mofetil and steroids on renal function after kidney transplantation. Nephrol Dial Transplant 2010;25(1):283-92.


2009
Teschner S, Gerke P, Geyer M, Wilpert J, Krumme B, Benzing T, et al. Leflunomide therapy for polyomavirus-induced allograft nephropathy: efficient BK virus elimination without increased risk of rejection. Transplant Proc 2009;41(6):2533-8.

Rumberger B, Kreutz C, Nickel C, Klein M, Lagoutte S, Teschner S, et al. Combination of immunosuppressive drugs leaves specific "fingerprint" on gene expression in vitro. Immunopharmacol Immunotoxicol 2009;31(2):283-92.

Markert E, Siebolts U, Habbig S, Odenthal M, Dienes HP, Stippel DL, et al. Evolution of PTLD following renal transplantation in a child. Pediatr Transplant 2009;13(3):379-83.
Madershahian N, Liakopoulos OJ, Wippermann J, Salehi-Gilani S, Wittwer T, Choi YH, et al. The impact of intraaortic balloon counterpulsation on bypass graft flow in patients with peripheral ECMO. J Card Surg 2009;24(3):265-8.

Langenbach M, Stippel A, Stippel D. Kidney donors' quality of life and subjective evaluation at 2 years after donation. Transplant Proc 2009;41(6):2512-4.

Hoppe B, Beck BB, Milliner DS. The primary hyperoxalurias. Kidney Int 2009;75(12):1264-71.
Habbig S, Beck BB, Feldkotter M, Korber F, Laffeber C, Verkoelen C, et al. Renal allograft calcification -- prevalence and etiology in pediatric patients. Am J Nephrol 2009;30(3):194-200.

Brinkert F, Ganschow R, Helmke K, Harps E, Fischer L, Nashan B, et al. Transplantation procedures in children with primary hyperoxaluria type 1: outcome and longitudinal growth. Transplantation 2009;87(9):1415-21.


2008
Wittwer T, Wahlers T. Marginal donor grafts in heart transplantation: lessons learned from 25 years of experience. Transpl Int 2008;21(2):113-25.

Strauch JT, Wippermann J, Krep H, Wahlers T. Subannular perforation after long-lasting aortic valve replacement mimicking mitral insufficiency. Ann Thorac Surg 2008;85(1):311-3.

Schleimer K, Stippel DL, Kasper HU, Allwissner R, Yavuzyasar S, Holscher AH, et al. Competition between native liver and graft in auxiliary liver transplantation in a rat model. Transplant Proc 2008;40(4):967-70.

Offner G, Toenshoff B, Hocker B, Krauss M, Bulla M, Cochat P, et al. Efficacy and safety of basiliximab in pediatric renal transplant patients receiving cyclosporine, mycophenolate mofetil, and steroids. Transplantation 2008;86(9):1241-8.

Madershahian N, Wittwer T, Strauch J, Wippermann J, Rahmanian P, Franke UF, et al. Kinetic of procalcitonin in the early postoperative course following heart transplantation. J Card Surg 2008;23(5):468-73.

Hoppe BS, Moskowitz CH, Filippa DA, Moskowitz CS, Kewalramani T, Zelenetz AD, et al. Involved-field radiotherapy before high-dose therapy and autologous stem-cell rescue in diffuse large-cell lymphoma: long-term disease control and toxicity. J Clin Oncol 2008;26(11):1858-64.

Hocker B, Kovarik JM, Daniel V, Opelz G, Fehrenbach H, Holder M, et al. Pharmacokinetics and immunodynamics of basiliximab in pediatric renal transplant recipients on mycophenolate mofetil comedication. Transplantation 2008;86(9):1234-40.

Groetzner J, Kaczmarek I, Wittwer T, Strauch J, Meiser B, Wahlers T, et al. Caspofungin as first-line therapy for the treatment of invasive aspergillosis after thoracic organ transplantation. J Heart Lung Transplant 2008;27(1):1-6.


2007
Wilpert J, Geyer M, Pisarski P, Drognitz O, Schulz-Huotari C, Gropp A, et al. On-demand strategy as an alternative to conventionally scheduled post-transplant immunoadsorptions after ABO-incompatible kidney transplantation. Nephrol Dial Transplant 2007;22(10):3048-51.

Nierhoff D, Levoci L, Schulte S, Goeser T, Rogler LE, Shafritz DA. New cell surface markers for murine fetal hepatic stem cells identified through high density complementary DNA microarrays. Hepatology 2007;46(2):535-47.

Wilpert J, Geyer M, Teschner S, Schaefer T, Pisarski P, Schulz-Huotari C, et al. ABO-incompatible kidney transplantation-proposal of an intensified apheresis strategy for patients with high initial isoagglutinine titers. J Clin Apher 2007;22(6):314-22.

Madershahian N, Wittwer T, Franke UF, Wippermann J, Strauch J, Groetzner J, et al. Effect of induction therapy on kinetic of procalcitonin following uncomplicated heart transplantation. J Card Surg 2007;22(3):199-202.

Lauten A, Franke U, Strauch JT, Kaluza M, Wahlers T. Postocardiotomy failure after Ross operation: implantation of intravascular flow pump through pulmonary autograft. Thorac Cardiovasc Surg 2007;55(6):399-400.

Hoppe B, Salama A. Sequencing-based typing of HLA. Methods Mol Med 2007;134:71-80.

Geyer M, Donauer J, Pisarski P, Drognitz O, Schulz-Huotari C, Wisniewski U, et al. Preemptive postoperative antigen-specific immunoadsorption in ABO-incompatible kidney transplantation: necessary or not? Transplantation 2007;84(12 Suppl):S40-3.


2006
Wittwer T, Franke UF, Sandhaus T, Groetzner J, Strauch JT, Wippermann J, et al. Endobronchial donor pre-treatment with ventavis: is a second administration during reperfusion beneficial to optimize post-ischemic function of non-heart beating donor lungs? J Surg Res 2006;136(1):136-42.

Teschner S, Geyer M, Wilpert J, Schwertfeger E, Schenk T, Walz G, et al. Remission of polyomavirus-induced graft nephropathy treated with low-dose leflunomide. Nephrol Dial Transplant 2006;21(7):2039-40.

Stippel DL, Bangard C, Schleimer K, Koerber F, Beckurts KT, Hoppe B. Successful renal transplantation in a child with thrombosis of the inferior vena cava and both iliac veins. Transplant Proc 2006;38(3):688-90.

Gouon-Evans V, Boussemart L, Gadue P, Nierhoff D, Koehler CI, Kubo A, et al. BMP-4 is required for hepatic specification of mouse embryonic stem cell-derived definitive endoderm. Nat Biotechnol 2006;24(11):1402-11.

Ju W, Ogawa A, Heyer J, Nierhof D, Yu L, Kucherlapati R, et al. Deletion of Smad2 in mouse liver reveals novel functions in hepatocyte growth and differentiation. Mol Cell Biol 2006;26(2):654-67.

Shafritz DA, Oertel M, Menthena A, Nierhoff D, Dabeva MD. Liver stem cells and prospects for liver reconstitution by transplanted cells. Hepatology 2006;43(2 Suppl 1):S89-98.

Schleimer K, Stippel DL, Kasper HU, Tawadros S, Allwissner R, Gaudig C, et al. Portal hyperperfusion causes disturbance of microcirculation and increased rate of hepatocellular apoptosis: investigations in heterotopic rat liver transplantation with portal vein arterialization. Transplant Proc 2006;38(3):725-9.

Schleimer K, Stippel DL, Kasper HU, Suer C, Tawadros S, Holscher AH, et al. Physiologic microcirculation of the heterotopically transplanted rat liver with portal vein arterialization depending on optimal stent diameter. Med Sci Monit 2006;12(4):BR140-5.

Schleimer K, Stippel DL, Tawadros S, Holzen J, Holscher AH, Beckurts KT. Improved technique of heterotopic auxiliary rat liver transplantation with portal vein arterialization. Langenbecks Arch Surg 2006;391(2):102-7.

Schleimer K, Stippel DL, Kasper HU, Tawadros S, Suer C, Schomacker K, et al. Auxiliary liver transplantation with flow-regulated portal vein arterialization offers a successful therapeutic option in acute hepatic failure--investigations in heterotopic auxiliary rat liver transplantation. Transpl Int 2006;19(7):581-8.

Hoppe B, Beck B, Gatter N, von Unruh G, Tischer A, Hesse A, et al. Oxalobacter formigenes: a potential tool for the treatment of primary hyperoxaluria type 1. Kidney Int 2006;70(7):1305-11.


2005
Tox U, Goeser T. [Therapy of complications of hepatic cirrhosis]. Praxis (Bern 1994) 2005;94(18):727-33.

Stippel DL, Kasper HU, Schleimer K, Tox U, Bangard C, Holscher AH, et al. Successful use of sirolimus in a patient with bulky ovarian metastasis of hepatocellular carcinoma after liver transplantation. Transplant Proc 2005;37(5):2185-7.

Nierhoff D, Ogawa A, Oertel M, Chen YQ, Shafritz DA. Purification and characterization of mouse fetal liver epithelial cells with high in vivo repopulation capacity. Hepatology 2005;42(1):130-9.

Stapenhorst L, Sassen R, Beck B, Laube N, Hesse A, Hoppe B. Hypocitraturia as a risk factor for nephrocalcinosis after kidney transplantation. Pediatr Nephrol 2005;20(5):652-6.

Muller A, Beck B, Theilemann K, Stapenhorst L, Licht C, Michalk D, et al. Detection of polyomavirus BK and JC in children with kidney diseases and renal transplant recipients. Pediatr Infect Dis J 2005;24(9):778-81.

Leumann E, Hoppe B. Primary hyperoxaluria type 1: is genotyping clinically helpful? Pediatr Nephrol 2005;20(5):555-7.

Hoppe B, Latta K, von Schnakenburg C, Kemper MJ. Primary hyperoxaluria--the German experience. Am J Nephrol 2005;25(3):276-81.


2004
Schleimer K, Stippel DL, Kasper HU, Suer C, Tawadros S, Hoelscher AH, et al. Improved microcirculation of a liver graft by controlled portal vein arterialization. J Surg Res 2004;116(2):202-10.

Langenbach M, Stippel D, Beckurts KT, Geisen J, Kohle K. [How do patients experience their body after simultaneous pancreas-kidney transplantation? ]. Z Psychosom Med Psychother 2004;50(1):86-102.

Kasper HU, Dries V, Drebber U, Stippel D, Reinhold K, Dienes HP. Florid ischemic cholangitis due to leucocytoclastic vasculitis. J Gastroenterol 2004;39(2):188-91.

Beckurts KT, Stippel D, Schleimer K, Schafer H, Benz C, Dienes HP, et al. First case of isolated small bowel transplantation at the university of cologne: rejection-free course under quadruple immunosuppression and endoluminal monitoring with video-capsule. Transplant Proc 2004;36(2):340-2.


2003
Stippel DL, Kasper HU, Schleimer K, Benz C, Holscher AH, Beckurts KT. Underestimation of nodules while staging hepatocellular carcinoma prior to neoadjuvant treatment on waiting list for transplantation. Transplant Proc 2003;35(4):1423-4.

Sachinidis A, Gissel C, Nierhoff D, Hippler-Altenburg R, Sauer H, Wartenberg M, et al. Identification of plateled-derived growth factor-BB as cardiogenesis-inducing factor in mouse embryonic stem cells under serum-free conditions. Cell Physiol Biochem 2003;13(6):423-9.

Petersen-Benz C, Hoffmann N, Beckurts T, Goeser T, Steffen HM, Dries V. Fulminant liver failure induced by hepatosplenic alphabeta T-cell lymphoma. Z Gastroenterol 2003;41(11):1083-6.

Langenbach M, Stippel D, Beckurts KT, Kohle K. [Patients' subjective experiences after liver transplantation]. Zentralbl Chir 2003;128(10):842-8.

Hoppe B, Langman CB. A United States survey on diagnosis, treatment, and outcome of primary hyperoxaluria. Pediatr Nephrol 2003;18(10):986-91.

Hoppe BL, Hermann DD. Sex differences in the causes and natural history of heart failure. Curr Cardiol Rep 2003;5(3):193-9.

Gutschow CA, Schafer H, Beckurts KT, Schroder W, Holscher AH. Endoscopic stapling technique for redundant free jejunal interposition graft. Dis Esophagus 2003;16(2):139-41.

Benz C, Holz G, Michel D, Awerkiew S, Dries V, Stippel D, et al. Viral escape and T-cell immunity during ganciclovir treatment of cytomegalovirus infection: case report of a pancreatico-renal transplant recipient. Transplantation 2003;75(5):724-7.


2002
Stippel DL, Arns W, Pollok M, Beckurts KT, Hesse UJ, Holscher AH. ALG versus OKT3 for treatment of steroid-resistant rejection in renal transplantation: ten-year follow-up results of a randomized trial. Transplant Proc 2002;34(6):2201-2.

Licht C, Hell K, Eifinger F, Hoppe B, Querfeld U. Posttransplant lymphoproliferative disease in a child: clinical and molecular characterization. Pediatr Nephrol 2002;17(2):79-84.

Benz C, Utermohlen O, Wulf A, Villmow B, Dries V, Goeser T, et al. Activated virus-specific T cells are early indicators of anti-CMV immune reactions in liver transplant patients. Gastroenterology 2002;122(5):1201-15.

Tox U, Burkhardt MA, Benz C, Arnold JC, Otto G, Theilmann L, et al. Expression of apoptosis and apoptosis-related peptides in various stages of rejection in the human transplanted liver. Hepatogastroenterology 2001;48(42):1697-700.


2001
Leumann E, Hoppe B. The primary hyperoxalurias. J Am Soc Nephrol 2001;12(9):1986-93.

Beckurts UT, Stippel D, Pollok M, Arns W, Weber M, Holscher AH. Single-center experience with the "Old for Old" program for renal transplantation. Transplant Proc 2001;33(7-8):3779-80.


2000
Nierhoff D, Horvath HC, Mytilineos J, Golling M, Bud O, Klar E, et al. Microchimerism in bone marrow-derived CD34(+) cells of patients after liver transplantation. Blood 2000;96(2):763-7.

Leumann E, Hoppe B. Pre-emptive liver transplantation in primary hyperoxaluria type 1: a controversial issue. Pediatr Transplant 2000;4(3):161-4.

Kugel H, Wittsack HJ, Wenzel F, Stippel D, Heindel W, Lackner K. Non-invasive determination of metabolite concentrations in human transplanted kidney in vivo by 31P MR spectroscopy. Acta Radiol 2000;41(6):634-41.


1999
Mohr M, Hilgenfeld E, Fietz T, Hoppe B, Koenigsmann M, Hoffmann M, et al. Efficacy and safety of simultaneous immunomagnetic CD34+ cell selection and breast cancer cell purging in peripheral blood progenitor cell samples used for hematopoietic rescue after high-dose therapy. Clin Cancer Res 1999;5(5):1035-40.

Leumann E, Hoppe B. What is new in primary hyperoxaluria? Nephrol Dial Transplant 1999;14(11):2556-8.

Hoppe B, Kemper MJ, Bokenkamp A, Portale AA, Cohn RA, Langman CB. Plasma calcium oxalate supersaturation in children with primary hyperoxaluria and end-stage renal failure. Kidney Int 1999;56(1):268-74.

Hoppe B, Mohr M, Roots-Weiss A, Kienast J, Berdel WE. Improvement of tumor cell depletion by combining immunomagnetic positive selection of CD34-positive hematopoietic stem cells and negative selection (purging) of tumor cells. Bone Marrow Transplant 1999;23(8):809-17.


1998
Stippel D, Heindel W, Beckurts T, Kugel H, Wenzel F. [Volume selective 31P NMR spectroscopy for differentiation of graph rejection and acute tubular necrosis after kidney transplantation]. Langenbecks Arch Chir Suppl Kongressbd 1998;115(Suppl I):155-9.


1997
Roots-Weiss A, Papadimitriou C, Serve H, Hoppe B, Koenigsmann M, Reufi B, et al. The efficiency of tumor cell purging using immunomagnetic CD34+ cell separation systems. Bone Marrow Transplant 1997;19(12):1239-46.

Muller-Berghaus J, Hoppe B, Schmidt R, Wagner M, Querfeld U. A transplanted child with severe hypercalcaemic hyperparathyroidism despite only modest bone lesions. Nephrol Dial Transplant 1997;12(11):2445-6.

Krings F, Stippel D, Vorreuther R, Schmidt R. Reconstruction of a totally necrotic renal collecting system and ureter after living donor transplantation using the Boari flap technique. Eur J Surg 1997;163(1):73-6.

Heindel W, Kugel H, Wenzel F, Stippel D, Schmidt R, Lackner K. Localized 31P MR spectroscopy of the transplanted human kidney in situ shows altered metabolism in rejection and acute tubular necrosis. J Magn Reson Imaging 1997;7(5):858-64.

Beckurts KT, Holscher AH, Heidecke CD, Zilker TR, Natrath W, Siewert JR. [The role of liver transplantation in the treatment of acute liver failure following Amanita phalloides poisoning]. Dtsch Med Wochenschr 1997;122(12):351-5.

Beckurts KT, Holscher AH, Bauer TH, Siewert JR. [Malignant tumors of the hepatic bifurcation--results of surgical therapy and prognostic factors]. Chirurg 1997;68(4):378-84.


1996
Schmidt R, Stippel D, Schmitz-Rixen T, Pollok M. Tumors after renal transplantation. Urol Int 1996;57(1):21-6.

Knauf WU, Koenigsmann MP, Notter M, Hoppe B, Reufi B, Oberberg D, et al. Peripheral blood progenitor cell mobilization with Dexa-Beam/G-CSF, ether lipid purging, and autologous transplantation after high-dose CBV treatment: a safe and effective regimen in patients with poor risk malignant lymphomas. Leuk Lymphoma 1996;23(3-4):305-11.


1995
Schmidt R, Stippel D, Krings F, Pollok M. Malignancies of the genito-urinary system following renal transplantation. Br J Urol 1995;75(5):572-7.


1993
Wienand P, Isenberg J, Stippel D, Schroder T, Baldamus C. Cyclosporin A: early or delayed onset by prophylactic immunosuppression? Nephrol Dial Transplant 1993;8(4):366-8.


1992
Wienand P, Schroder T, Stippel D, Baldamus C. Donor conditions and graft survival--a retrospective study. Transpl Int 1992;5 Suppl 1:S151-2.

Stippel D, Wienand P, Weissenberg N, Baldamus C, Kruppenbacher U. CMV prophylaxis after renal transplantation with immunoglobulin or CMV-hyperimmunoglobulin--a prospective clinical trial. Transpl Int 1992;5 S146-7.


1991
Wienand P, Schroder T, Stippel D, Baldamus C. Which donor factors have an influence on recipient and graft survival? Retrospective analysis of 308 renal transplants at a single centre. Transplant Proc 1991;23(5):2560-2.

nach oben